Skip to main content
CMEducation Resources ScrollCall
  • menu
  • menu
  • person
  • Search
  • Specialty
  • Cardiology chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • Diabetes chevron_right

  • Specialty Program
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Glycemic Regulation chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • Specialty Program
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Cytokine Immunotherapy chevron_right
  • Hypothyroidism chevron_right
  • Specialty Program
  • Parkinson's Diseasechevron_right
  • Specialty
  • Cancer chevron_right

  • Specialty Program
  • Cytokine Immunotherapy chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Pain Management chevron_right
  • Specialty
  • Primary Care chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Congenital Adrenal Hyperplasia (CAH) chevron_right
  • Fabry Disease chevron_right
  • Hypothyroidism chevron_right
  • Parkinson's Diseasechevron_right
  • Pain Management chevron_right
  • Glycemic Regulation chevron_right
  • Specialty
  • Dermatology chevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Extracorporeal Photopheresis (ECP) chevron_right
  • Specialty
  • Biologicschevron_right

  • Specialty Program
  • Atopic Dermatitischevron_right
  • Cytokine Immunotherapy chevron_right
  • Fabry Disease chevron_right
  • Biosimilars for RA chevron_right
  • PCSK9s in Interventional Cardiology chevron_right
  • PCSK9s in Medical Preventative chevron_right
  • PCSK9s in Lipid Medicine & Atherosclerosis Prevention chevron_right
  • PCSK9s in Diabetes Management chevron_right
  • PCSK9s: A Multi-Specialty Perspective chevron_right
  • Specialty
  • MAC Lung Disease chevron_right

  • Specialty Program
  • MAC Lung Disease chevron_right
    • close
    CMEducation Resources iQ&A
    • person
    • Home
    • Specialtieschevron_right
      • chevron_leftTopics
      • Cardiology
      • Diabetes
      • Endocrinology
      • Neurology
      • Cancer
      • Primary Care
      • Dermatology
      • Biologics
      • MAC Lung Disease
    • Submit A Question
    close

    Errol R. Norwitz, MD, PhD, MBA

    Errol R. Norwitz, MD, PhD, MBA

    Louis E. Phaneuf Professor of Obstetrics & Gynecology 
    Tufts University School of Medicine
    Chairman, Department of Obstetrics & Gynecology
    Tufts Medical Center
    Boston, MA 


    Related Videos

    What do we know about the cost-effectiveness and superiority of NIPT? Why is the SNP-based NIPT more cost-effective than serum screening? Video

    What do we know about the cost-effectiveness and superiority of NIPT? Why is the SNP-based NIPT more cost-effective than serum screening?

    What do we know about the cost-effectiveness and superiority of NIPT? Why is the SNP-based NIPT more cost-effective than serum screening?

    What follow-up should be done when NIPT is discrepant with ultrasound for fetal sex? Video

    What follow-up should be done when NIPT is discrepant with ultrasound for fetal sex?

    What follow-up should be done when NIPT is discrepant with ultrasound for fetal sex?

    What distinct advantages does SNP-based technology offer in resolving the cause of the abnormal result, including the presence or absence of maternal findings and vanishing twins? Video

    What distinct advantages does SNP-based technology offer in resolving the cause of the abnormal result, including the presence or absence of maternal findings and vanishing twins?

    What distinct advantages does SNP-based technology offer in resolving the cause of the abnormal result, including the presence or absence of maternal findings and vanishing twins?

    What are some of the reasons for rare false positive NIPT results? Video

    What are some of the reasons for rare false positive NIPT results?

    What are some of the reasons for rare false positive NIPT results?

    What tools are available to help providers explain NIPT to patients? Video

    What tools are available to help providers explain NIPT to patients?

    What tools are available to help providers explain NIPT to patients?

    What can a provider expect with respect to timing of results, reporting methods and technical support for NIPT results? Video

    What can a provider expect with respect to timing of results, reporting methods and technical support for NIPT results?

    What can a provider expect with respect to timing of results, reporting methods and technical support for NIPT results?

    What algorithm(s) can OBs and MFMs use to integrate NIPT into prenatal care? And how do you utilize NIPT in your practice? As a first-line test? Video

    What algorithm(s) can OBs and MFMs use to integrate NIPT into prenatal care? And how do you utilize NIPT in your practice? As a first-line test?

    What algorithm(s) can OBs and MFMs use to integrate NIPT into prenatal care? And how do you utilize NIPT in your practice? As a first-line test?

    With respect to fetal fraction, why is cell-free DNA, SNP-based technology superior? Video

    With respect to fetal fraction, why is cell-free DNA, SNP-based technology superior?

    With respect to fetal fraction, why is cell-free DNA, SNP-based technology superior?

    How do gestational age and maternal weight (BMI) affect fetal fraction? And what is the importance of separating out maternal fraction from fetal fraction by NIPT? Video

    How do gestational age and maternal weight (BMI) affect fetal fraction? And what is the importance of separating out maternal fraction from fetal fraction by NIPT?

    How do gestational age and maternal weight (BMI) affect fetal fraction? And what is the importance of separating out maternal fraction from fetal fraction by NIPT?

    Disclaimer:
    Copyright © by CMEducation Resources, LLC All rights reserved. Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
    Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.
    Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.
    Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

    Clinical Webcasts®

    Powered by BroadcastMedBROADCASTMED